IBDEI106 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16314,0)
;;=F52.0^^61^772^62
;;^UTILITY(U,$J,358.3,16314,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16314,1,3,0)
;;=3^Hypoactive Sexual Desire Disorder
;;^UTILITY(U,$J,358.3,16314,1,4,0)
;;=4^F52.0
;;^UTILITY(U,$J,358.3,16314,2)
;;=^5003618
;;^UTILITY(U,$J,358.3,16315,0)
;;=F52.22^^61^772^105
;;^UTILITY(U,$J,358.3,16315,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16315,1,3,0)
;;=3^Sexual Arousal Disorder,Female
;;^UTILITY(U,$J,358.3,16315,1,4,0)
;;=4^F52.22
;;^UTILITY(U,$J,358.3,16315,2)
;;=^5003621
;;^UTILITY(U,$J,358.3,16316,0)
;;=F52.8^^61^772^106
;;^UTILITY(U,$J,358.3,16316,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16316,1,3,0)
;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
;;^UTILITY(U,$J,358.3,16316,1,4,0)
;;=4^F52.8
;;^UTILITY(U,$J,358.3,16316,2)
;;=^5003624
;;^UTILITY(U,$J,358.3,16317,0)
;;=F52.21^^61^772^35
;;^UTILITY(U,$J,358.3,16317,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16317,1,3,0)
;;=3^Erectile Disorder,Male (Psychogenic)
;;^UTILITY(U,$J,358.3,16317,1,4,0)
;;=4^F52.21
;;^UTILITY(U,$J,358.3,16317,2)
;;=^5003620
;;^UTILITY(U,$J,358.3,16318,0)
;;=I12.9^^61^772^61
;;^UTILITY(U,$J,358.3,16318,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16318,1,3,0)
;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
;;^UTILITY(U,$J,358.3,16318,1,4,0)
;;=4^I12.9
;;^UTILITY(U,$J,358.3,16318,2)
;;=^5007066
;;^UTILITY(U,$J,358.3,16319,0)
;;=N04.9^^61^772^78
;;^UTILITY(U,$J,358.3,16319,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16319,1,3,0)
;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,16319,1,4,0)
;;=4^N04.9
;;^UTILITY(U,$J,358.3,16319,2)
;;=^5015540
;;^UTILITY(U,$J,358.3,16320,0)
;;=N02.9^^61^772^55
;;^UTILITY(U,$J,358.3,16320,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16320,1,3,0)
;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
;;^UTILITY(U,$J,358.3,16320,1,4,0)
;;=4^N02.9
;;^UTILITY(U,$J,358.3,16320,2)
;;=^5015520
;;^UTILITY(U,$J,358.3,16321,0)
;;=N06.9^^61^772^95
;;^UTILITY(U,$J,358.3,16321,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16321,1,3,0)
;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
;;^UTILITY(U,$J,358.3,16321,1,4,0)
;;=4^N06.9
;;^UTILITY(U,$J,358.3,16321,2)
;;=^5015558
;;^UTILITY(U,$J,358.3,16322,0)
;;=N05.9^^61^772^75
;;^UTILITY(U,$J,358.3,16322,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16322,1,3,0)
;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
;;^UTILITY(U,$J,358.3,16322,1,4,0)
;;=4^N05.9
;;^UTILITY(U,$J,358.3,16322,2)
;;=^5134086
;;^UTILITY(U,$J,358.3,16323,0)
;;=N07.9^^61^772^77
;;^UTILITY(U,$J,358.3,16323,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16323,1,3,0)
;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
;;^UTILITY(U,$J,358.3,16323,1,4,0)
;;=4^N07.9
;;^UTILITY(U,$J,358.3,16323,2)
;;=^5015568
;;^UTILITY(U,$J,358.3,16324,0)
;;=N15.9^^61^772^102
;;^UTILITY(U,$J,358.3,16324,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16324,1,3,0)
;;=3^Renal Tubulo-Interstitial Disease,Unspec
;;^UTILITY(U,$J,358.3,16324,1,4,0)
;;=4^N15.9
;;^UTILITY(U,$J,358.3,16324,2)
;;=^5015596
;;^UTILITY(U,$J,358.3,16325,0)
;;=N17.9^^61^772^67
;;^UTILITY(U,$J,358.3,16325,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16325,1,3,0)
;;=3^Kidney Failure,Acute,Unspec
;;^UTILITY(U,$J,358.3,16325,1,4,0)
;;=4^N17.9
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI106 3756 printed Apr 09, 2024@21:06:18 Page 2
IBDEI106 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16314,0)
+2 ;;=F52.0^^61^772^62
+3 ;;^UTILITY(U,$J,358.3,16314,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,16314,1,3,0)
+6 ;;=3^Hypoactive Sexual Desire Disorder
+7 ;;^UTILITY(U,$J,358.3,16314,1,4,0)
+8 ;;=4^F52.0
+9 ;;^UTILITY(U,$J,358.3,16314,2)
+10 ;;=^5003618
+11 ;;^UTILITY(U,$J,358.3,16315,0)
+12 ;;=F52.22^^61^772^105
+13 ;;^UTILITY(U,$J,358.3,16315,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,16315,1,3,0)
+16 ;;=3^Sexual Arousal Disorder,Female
+17 ;;^UTILITY(U,$J,358.3,16315,1,4,0)
+18 ;;=4^F52.22
+19 ;;^UTILITY(U,$J,358.3,16315,2)
+20 ;;=^5003621
+21 ;;^UTILITY(U,$J,358.3,16316,0)
+22 ;;=F52.8^^61^772^106
+23 ;;^UTILITY(U,$J,358.3,16316,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,16316,1,3,0)
+26 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
+27 ;;^UTILITY(U,$J,358.3,16316,1,4,0)
+28 ;;=4^F52.8
+29 ;;^UTILITY(U,$J,358.3,16316,2)
+30 ;;=^5003624
+31 ;;^UTILITY(U,$J,358.3,16317,0)
+32 ;;=F52.21^^61^772^35
+33 ;;^UTILITY(U,$J,358.3,16317,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,16317,1,3,0)
+36 ;;=3^Erectile Disorder,Male (Psychogenic)
+37 ;;^UTILITY(U,$J,358.3,16317,1,4,0)
+38 ;;=4^F52.21
+39 ;;^UTILITY(U,$J,358.3,16317,2)
+40 ;;=^5003620
+41 ;;^UTILITY(U,$J,358.3,16318,0)
+42 ;;=I12.9^^61^772^61
+43 ;;^UTILITY(U,$J,358.3,16318,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,16318,1,3,0)
+46 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
+47 ;;^UTILITY(U,$J,358.3,16318,1,4,0)
+48 ;;=4^I12.9
+49 ;;^UTILITY(U,$J,358.3,16318,2)
+50 ;;=^5007066
+51 ;;^UTILITY(U,$J,358.3,16319,0)
+52 ;;=N04.9^^61^772^78
+53 ;;^UTILITY(U,$J,358.3,16319,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,16319,1,3,0)
+56 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
+57 ;;^UTILITY(U,$J,358.3,16319,1,4,0)
+58 ;;=4^N04.9
+59 ;;^UTILITY(U,$J,358.3,16319,2)
+60 ;;=^5015540
+61 ;;^UTILITY(U,$J,358.3,16320,0)
+62 ;;=N02.9^^61^772^55
+63 ;;^UTILITY(U,$J,358.3,16320,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,16320,1,3,0)
+66 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
+67 ;;^UTILITY(U,$J,358.3,16320,1,4,0)
+68 ;;=4^N02.9
+69 ;;^UTILITY(U,$J,358.3,16320,2)
+70 ;;=^5015520
+71 ;;^UTILITY(U,$J,358.3,16321,0)
+72 ;;=N06.9^^61^772^95
+73 ;;^UTILITY(U,$J,358.3,16321,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,16321,1,3,0)
+76 ;;=3^Proteinuria Isolated w/ Unspec Morphologic Lesion
+77 ;;^UTILITY(U,$J,358.3,16321,1,4,0)
+78 ;;=4^N06.9
+79 ;;^UTILITY(U,$J,358.3,16321,2)
+80 ;;=^5015558
+81 ;;^UTILITY(U,$J,358.3,16322,0)
+82 ;;=N05.9^^61^772^75
+83 ;;^UTILITY(U,$J,358.3,16322,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,16322,1,3,0)
+86 ;;=3^Nephritic Syndrome w/ Unspec Morphologic Changes
+87 ;;^UTILITY(U,$J,358.3,16322,1,4,0)
+88 ;;=4^N05.9
+89 ;;^UTILITY(U,$J,358.3,16322,2)
+90 ;;=^5134086
+91 ;;^UTILITY(U,$J,358.3,16323,0)
+92 ;;=N07.9^^61^772^77
+93 ;;^UTILITY(U,$J,358.3,16323,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,16323,1,3,0)
+96 ;;=3^Nephropathy Hereditary w/ Unspec Morphologic Lesions
+97 ;;^UTILITY(U,$J,358.3,16323,1,4,0)
+98 ;;=4^N07.9
+99 ;;^UTILITY(U,$J,358.3,16323,2)
+100 ;;=^5015568
+101 ;;^UTILITY(U,$J,358.3,16324,0)
+102 ;;=N15.9^^61^772^102
+103 ;;^UTILITY(U,$J,358.3,16324,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,16324,1,3,0)
+106 ;;=3^Renal Tubulo-Interstitial Disease,Unspec
+107 ;;^UTILITY(U,$J,358.3,16324,1,4,0)
+108 ;;=4^N15.9
+109 ;;^UTILITY(U,$J,358.3,16324,2)
+110 ;;=^5015596
+111 ;;^UTILITY(U,$J,358.3,16325,0)
+112 ;;=N17.9^^61^772^67
+113 ;;^UTILITY(U,$J,358.3,16325,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,16325,1,3,0)
+116 ;;=3^Kidney Failure,Acute,Unspec
+117 ;;^UTILITY(U,$J,358.3,16325,1,4,0)
+118 ;;=4^N17.9
